Dhampur Bio Valuation
| DBOL Stock | 126.64 1.10 0.88% |
At this time, the firm appears to be overvalued. Dhampur Bio Organics shows a prevailing Real Value of USD112.75 per share. The current price of the firm is USD126.64. Our model computes the value of Dhampur Bio Organics from reviewing the firm fundamentals such as Profit Margin of 0.01 %, operating margin of (0.04) %, and Current Valuation of 13.72 B as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 0.8576 | Enterprise Value 13.7 B | Enterprise Value Ebitda 11.3353 | Price Sales 0.5013 | Trailing PE 80.0633 |
Overvalued
Today
Please note that Dhampur Bio's price fluctuation is very steady at this time. Calculation of the real value of Dhampur Bio Organics is based on 3 months time horizon. Increasing Dhampur Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Dhampur stock is determined by what a typical buyer is willing to pay for full or partial control of Dhampur Bio Organics. Since Dhampur Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dhampur Stock. However, Dhampur Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 126.64 | Real 112.75 | Hype 126.58 |
The intrinsic value of Dhampur Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Dhampur Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Dhampur Bio Organics helps investors to forecast how Dhampur stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dhampur Bio more accurately as focusing exclusively on Dhampur Bio's fundamentals will not take into account other important factors: Dhampur Bio Cash |
|
Dhampur Bio Total Value Analysis
Dhampur Bio Organics is currently projected to have takeover price of 13.72 B with market capitalization of 8.4 B, debt of 10.57 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dhampur Bio fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.72 B | 8.4 B | 10.57 B |
Dhampur Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dhampur Bio has an asset utilization ratio of 79.53 percent. This implies that the Company is making USD0.8 for each dollar of assets. An increasing asset utilization means that Dhampur Bio Organics is more efficient with each dollar of assets it utilizes for everyday operations.Dhampur Bio Ownership Allocation
Dhampur Bio holds a total of 66.39 Million outstanding shares. Dhampur Bio Organics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.42 percent of Dhampur Bio Organics outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Dhampur Bio Profitability Analysis
The company reported the revenue of 18.39 B. Net Income was 464.9 M with profit before overhead, payroll, taxes, and interest of 0.About Dhampur Bio Valuation
The stock valuation mechanism determines Dhampur Bio's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Dhampur Bio Organics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dhampur Bio. We calculate exposure to Dhampur Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dhampur Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.3 B | 3.3 B |
Dhampur Bio Quarterly Retained Earnings |
|
Additional Tools for Dhampur Stock Analysis
When running Dhampur Bio's price analysis, check to measure Dhampur Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dhampur Bio is operating at the current time. Most of Dhampur Bio's value examination focuses on studying past and present price action to predict the probability of Dhampur Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dhampur Bio's price. Additionally, you may evaluate how the addition of Dhampur Bio to your portfolios can decrease your overall portfolio volatility.